ICAM1 and lung cancer: Furthermore, CBD (10) treatments rendered lung cancer cells more likely to attach to and be destroyed by lymphokine-activated killer (LAK) cells, and it was discovered that the overexpression of ICAM-1 was the cause of LAK cells’ enhanced activity [131].